VAERS reports by lot

GSK Varicella/Shingles lot 3LL4P: VAERS reports

36 VAERS reports list lot 3LL4P as a GSK Varicella/Shingles vaccine, received between 2019-07-17 and 2020-09-19. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
36
Reports
11%
Marked serious
0
With a death outcome
9
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)4026%
Injection-site / Local reaction3120%
Cardiac / Cardiovascular2114%
Neurological1510%
Allergic / Anaphylactic128%
Musculoskeletal128%
Dermatological (non-injection-site)96%
Gastrointestinal85%
Thrombotic / Hematological43%
Respiratory11%

Where reports came from

U.S. state of the reporter, where given (top 12).

Florida6
Indiana4
Virginia3
Maryland3
Wisconsin2
California2
North Carolina2
Texas2
Michigan1
Massachusetts1
Missouri1
Iowa1

Reports by month received

2019-078
2019-0813
2019-097
2019-101
2019-123
2020-011
2020-041
2020-071
2020-091

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.